GL1X · GenesisL1 explorer

Research workbench

Crystal structure of fusion inhibitor jnj-2408068 in complex with human respiratory syncytial virus fusion glycoprotein escape variant G143S stabilized in the prefusion state

Analyse Crystal structure of fusion inhibitor jnj-2408068 in complex with human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EAG
Type
protein
Length
426 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
W8RJF9
Ligands
5NK, SO4

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
F—protein426—W8RJF9

Ligands and binding sites

  • 5NK · 2-[[2-[[1-(2-azanylethyl)piperidin-4-yl]amino]-4-methyl-benzimidazol-1-yl]methyl]-6-methyl-pyridin-3-ol · ligand · chains F
  • SO4 · Sulfate ion · ion · 2 copies · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · chains F
  • TAR · D(-)-tartaric acid · additive · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6EAG · Crystal structure of fusion inhibitor jnj-2408068 in complex with human respiratory… · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.